Goldman Sachs Adjusts Price Target on Gilead Sciences (NASDAQ:GILD) to $85 From $84By legume / August 5, 2023 / Gilead Sciences, Goldman Sachs Goldman Sachs Adjusts Price Target on Gilead Sciences (NASDAQ:GILD) to $85 From $84, Maintains Neutral Rating.